Vnitr Lek 2005, 51(7-8):886-893

Rare forms of hereditary anaemia in the Czech and Slovak populations - β- and δβ-thalassaemia and unstable haemoglobin variants

V. Divoký1,2,*, S. Walczysková2, D. Pospíšilová3, M. Priwitzerová2, S. Takáčová2, I. Kostelecká2, M. Divoká1, Š. Rožmanová1, M. Jarošová1, J. Čermák4, K. Indrák1, Česko-slovenská kooperativní skupina pro diagnostiku hemoglobinopatií
1 Hemato-onkologická klinika Lékařské fakulty UP a FN, Olomouc, přednosta prof. MUDr. Karel Indrák, DrSc.
2 Ústav biologie Lékařské fakulty UP, Olomouc, přednosta doc. RNDr. Vladimír Divoký, Ph.D.
3 Dětská klinika Lékařské fakulty UP a FN, Olomouc, přednosta prof. MUDr. Vladimír Mihál, CSc.
4 Ústav hematologie a krevní transfuze, Praha, ředitel prof. MUDr. Pavel Klener, DrSc.

We present a review of the spectrum and frequency of mutations of the β-globin gene in the Czech and Slovak patients with clinical symptoms of β-thalassaemia or δβ-thalassaemia and of Heinz body haemolytic anaemia associated with unstable haemoglobinopathies. In the Czech and Slovak populations, β-thalassaemia appears to be an uncommon disorder, which, however, must be considered as the prevailing cause of congenital hypochromic microcytic anaemia. All β-thalassaemia patients were heterozygous, manifesting thalassaemia minor, with rare exceptions of dominantly inherited β-thalassaemia with phenotype that ranged from severe thalassaemia minor to thalassaemia intermedia. We hypothesize that genetic drift and migration in the past are responsible for introduction of the Mediterranean alleles, while several mutations, described in single families, originated locally in the Czech Republic and Slovakia.

Keywords: β-thalassaemia; Heinz body haemolytic anaemia; unstable haemoglobin variants; Czech and Slovak populations

Received: May 17, 2005; Accepted: May 17, 2005; Published: July 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Divoký V, Walczysková S, Pospíšilová D, Priwitzerová M, Takáčová S, Kostelecká I, et al.. Rare forms of hereditary anaemia in the Czech and Slovak populations - β- and δβ-thalassaemia and unstable haemoglobin variants. Vnitr Lek. 2005;51(7-8):886-893.
Download citation

References

  1. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2001; 2: 245-255. Go to original source... Go to PubMed...
  2. Nienhuis AW, Stamatoyannopoulos G. Hemoglobin switching. Cell 1978; 1: 307-315. Go to original source... Go to PubMed...
  3. Steinberg MH, Forget BG, Higgs D et al (eds). Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge: University Press 2001.
  4. Antonarakis SE, Kazazian HH Jr, Orkin SH. DNA polymorphism and molecular pathology of the human globin gene clusters. Hum Genet 1985; 69: 1-14. Go to original source... Go to PubMed...
  5. Shear HL, Grinberg L, Gilman J et al. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 1998; 92: 2520-2526. Go to original source...
  6. Clegg JB, Weatherall DJ. Thalassemia and malaria: new insights into an old problem. Proc Assoc Am Physicians 1999; 111: 278-282. Go to original source... Go to PubMed...
  7. Allen SJ, O'Donnell A, Alexander ND et al. α+-thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997; 94: 14736-14741. Go to original source... Go to PubMed...
  8. Indrak K, Brabec V, Indrakova J et al. Molecular characterization of β-thalassemia in Czechoslovakia. Hum Genet 1993; 88: 399-404. Go to original source... Go to PubMed...
  9. Indrák K, Divoký V, Brabec V et al. Molekulárně-genetická charakteristika α-, β- a δβ-thalassémií u 139 heterozygotů z 56 nepříbuzných rodin českého a slovenského původu. Vnitř Lék 1993; 39: 969-978. Go to original source... Go to PubMed...
  10. Indrák K, Divoký V, Brabec V et al. Dominantní β-talasemické alely v české a slovenské populaci [beta;-talasemické mutace v 112 (T-A) a 121 (G-T) a nestabilní hemoglobinová varianta Hradec Králové nebo α2β2 115 (Gl7) Ala-Asp]. Vnitř Lék 1994; 40: 223-230. Go to PubMed...
  11. Popovich BW, Rosenblatt DS, Kendall AG et al. Molecular characterization of an atypical β-thalassemia caused by a large deletion in the 5' β-globin gene region. Am J Hum Genet 1986; 39: 797-810.
  12. Divoky V, Indrak K, Mrug M et al. A novel mechanism of β-thalassemia: The insertion of L1 retrotransposable element into β-globin IVS II. Blood 1996; 88: 148a.
  13. Kimberland ML, Divoky V, Prchal J et al. Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum Mol Genet 1999; 8: 1557-1560. Go to original source... Go to PubMed...
  14. Stamatoyannopoulos G, Woodson R, Papayannopoulou T et al. Inclusion-body β-thalassemia trait. A form of β-thalassemia producing clinical manifestations in simple heterozygotes. N Engl J Med 1974; 290: 939-943. Go to original source... Go to PubMed...
  15. Kazazian HH Jr, Dowling CE, Hurwitz RL et al. Dominant thalassemia-like phenotypes associated with mutations in exon 3 of the β-globin gene. Blood 1992; 79: 3014-3018.
  16. Thein SL. Is it dominantly inherited β-thalassaemia or just a β-chain variant that is highly unstable? Br J Haematol 1999; 107: 12-21. Go to original source... Go to PubMed...
  17. Divoky V, Svobodova M, Indrak K et al. Hb Hradec Kralove (Hb HK) or α2β2 115 (G17) Ala→Asp, a severely unstable hemoglobin variant resulting in a dominant β-thalassemia trait in a Czech family. Hemoglobin 1993; 17: 319-328. Go to original source... Go to PubMed...
  18. Divoky V, Gu LH, Indrak K et al. A new β-thalassaemia nonsense mutation (codon 112, T→A) not associated with a dominant type of thalassaemia in the heterozygote. Br J Haematol 1993; 83: 523-524. Go to original source... Go to PubMed...
  19. Cooley TB, Lee P. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans Am Ped Soc 1925; 37: 29.
  20. Kutlar A, Huisman THJ. Detection of hemoglobinopathies. In Hommes FA (ed). Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual. New York: Wiley-Liss 1991: 519-560.
  21. Huisman TH (ed). The hemoglobinopathies. In Methods in hematology. Vol. 15. New York: Churchill Livingstone 1986.
  22. Indrák K, Brabec V, Divoký V et al. Strukturní varianty hemoglobinu nalezené v České republice. Vnitř Lék 1995; 41: 13-20. Go to PubMed...
  23. Indrak K, Brabec V, Wilson JB et al. Hb Köln or α2β2 98 (FG5) Val-Met in a Czechoslovakian. Hemoglobin 1991; 15: 133-135. Go to original source... Go to PubMed...
  24. Wiedermann B, Indrak K, Wilson JB et al. Hb Saint Louis or α2β2 28 (Bl0) Leu-Gln in a Czechoslovakian male. Hemoglobin 1986; 10: 673-676. Go to original source... Go to PubMed...
  25. Brabec V, Indrak K, Fortova H et al. Hb Nottingham or α2β2 98 (FG5) Val-Gly in a Czech child. Ann Hematol 1994; 69: 93-95. Go to original source... Go to PubMed...
  26. Divoký V, Hammerová T, Sakalová A et al. Nestabilní hemoglobin Santa Ana nebo α2β2 88 (F4) Leu-Pro identifikovaný u slovenské dívky. Vnitř Lék 1996; 42: 38-41.
  27. Indrák K, Divoký V, Kynčlová E et al. Hemoglobin Sydney α2β2 67 (E11) Val-Ala a hemoglobin Olomouc α2β2 86 (F2) Ala-Asp v českých rodinách. Přínos sekvenační analýzy DNA pro zpřesnění diagnostiky hemoglobinopatií. Vnitř Lék 1998; 44: 347-349. Go to PubMed...
  28. Divoky V, Pospisilova D, Luhovy M et al. HB-HANA or α2β2 63 (E7) His-Asn, a new unstable haemoglobin variant with variable clinical manifestation. Br J Haematol 1996; 93(Suppl): 88.
  29. Divoký V, Luhový M, Divoká M et al. Hemoglobin Haná nebo α2β2 63 (E7) His-Asn: nová nestabilní varianta hemoglobinu s paradoxně rozdílnou klinickou manifestací u kuřáků a nekuřáků z téže rodiny. Vnitř Lék 1997; 43: 267-272. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.